Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
This clinical trial studies diffusion-weighted magnetic resonance imaging (MRI) in identifying and localizing tumors in patients with non-small cell lung cancer undergoing radiation therapy. Diagnostic procedures such as diffusion weighted MRI may help identify where active cancer is to improve the targeting accuracy of radiotherapy. Comparing results of diagnostic procedures done before, during, and after radiation therapy may help determine how the location and volume of tumors changes over time and predict how the tumor will respond to therapy.
Checked against the public recordLast updated Dec 16, 2016 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Virginia Commonwealth University
- Interventions being studied
- Device: diffusion-weighted magnetic resonance imaging; Device: 4-dimensional computed tomography; Radiation: fludeoxyglucose F 18; Device: FDG-PET
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients must be able to undergo MRI imaging; contrast application will be determined according to institutional guidelines; patients with lung cancer or locally recurrent lung cancer (following surgery) who are scheduled to receive external beam radiation therapy for at least 6 weeks * Tumor visible on planning CT scan * Negative pregnancy test for women of childbearing potential prior to study entry Exclusion Criteria: * Patients requiring continuous supplemental oxygen * Patients with metal implants including pace makers and defibrillators * Patients with cerebral aneurysm clips or middle ear implant * Patients with pain pump, a programmable shunt, or non-surgical metal (i.e. a foreign body) * Claustrophobic patients * Prior radiotherapy to body area under investigation * No vulnerable populations will be enrolled (prisoners, children, pregnant females, or institutionalized individuals)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Virginia Commonwealth University Massey Cancer CenterRichmond, Virginia
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Dec 16, 2016. Always confirm current availability with the study team.